EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of 14-day high-dose dual therapy for Helicobacter pylori infection in Vietnam

Nam T Phan, Long H Truong

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Nam T Phan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Endoscopy Center, Hospital of Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Amoxicillin. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The eradication rates of Helicobacter pylori (H. pylori) in Vietnam, with both triple therapy and non-bismuth quadruple therapy, have significantly declined due to increasing antibiotic resistance. This prospective study aimed to evaluate the eradication efficacy of high-dose dual therapy (HDDT) with esomeprazole and amoxicillin in a region with high resistance rates to clarithromycin, metronidazole, and levofloxacin. Methodology: A total of 82 patients with active H. pylori infection, confirmed by either a rapid urease test or a ¹³C urea breath test, were enrolled at our hospital. All participants received esomeprazole (40 mg) and amoxicillin (1,000 mg), 3 times daily for 14 days. Treatment success was assessed using a ¹³C urea breath test 4–6 weeks post-treatment. Safety was evaluated based on reported adverse effects.

Results

Gastritis, gastric ulcer, and duodenal ulcer were present in 80.5%, 10.4%, and 9.1% of cases, respectively. The eradication rates according to intention-to-treat (ITT) and per-protocol (PP) analyses were 76.8% (63/82) and 81.8% (63/77), respectively. In the PP analysis, the eradication rate was 86.0% (49/57) in first-line treatment, and 70.0% (14/20) in patients with prior H. pylori treatment failure. Mild side effects, including nausea, abdominal discomfort, pruritus, diarrhea, and fatigue, were reported in 22.1% (17/77) of patients.

Conclusions

This study demonstrates that a 14-day HDDT regimen provides relatively high efficacy and a favorable safety profile for first-line H. pylori eradication. Given the widespread resistance to clarithromycin, levofloxacin, and metronidazole in Vietnam; HDDT may serve as an alternative first-line therapy for H. pylori eradication in this region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsAmoxicillinEsomeprazoleHumansMaleFemaleMiddle AgedAdultVietnamDrug Therapy, CombinationProspective StudiesTreatment OutcomeBreath TestsAgedYoung AdultUrea

Stichwörter der Autor:innen

HDDTHelicobacter pyloriPPIsamoxicillintreatment

Substanzen

Anti-Bacterial AgentsAmoxicillinEsomeprazoleUrea

Autor:innen und Institutionen

  • Gastroenterology and Endoscopy Center, Hospital of Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam.

Zitieren

APA

Phan, N. T., & Truong, L. H. (2025). Effectiveness of 14-day high-dose dual therapy for Helicobacter pylori infection in Vietnam. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20820

Vancouver

Phan NT, Truong LH. Effectiveness of 14-day high-dose dual therapy for Helicobacter pylori infection in Vietnam. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20820

BibTeX
@article{Phan2025,
  author = {Phan, Nam T and Truong, Long H},
  title = {Effectiveness of 14-day high-dose dual therapy for Helicobacter pylori infection in Vietnam},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20820}
}
Kostenlos starten →